GLOBUS MEDICAL INC
For the period ended Dec 31, 2023. Filed Feb 21, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 21, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| GLOBUS MEDICAL, INC. | ||
| Dated: | February 20, 2024 | /s/ DANIEL T. SCAVILLA |
|---|---|---|
| Daniel T. Scavilla | ||
| Chief Executive Officer | ||
| President | ||
| (Principal Executive Officer) | ||
| Dated: | February 20, 2024 | /s/ KEITH PFEIL |
| Keith Pfeil | ||
| Chief Financial Officer and Chief Operating Officer | ||
| Chief Accounting Officer | ||
| Senior Vice President | ||
| (Principal Financial Officer) | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| SIGNATURE | TITLE | DATE |
| /s/ DANIEL T. SCAVILLA | President and Chief Executive Officer | February 20, 2024 |
| Daniel T. Scavilla | (Principal Executive Officer) | |
| and Director | ||
| /s/ KEITH PFEIL | Chief Financial Officer and Chief Operating Officer | February 20, 2024 |
| Keith Pfeil | Chief Accounting Officer | |
| Senior Vice President | ||
| (Principal Financial Officer) | ||
| /s/ DAVID C. PAUL | Executive Chairman and Director | February 20, 2024 |
| David C. Paul | ||
| /s/ DAVID D. DAVIDAR | Director | February 20, 2024 |
| David D. Davidar | ||
| /s/ ROBERT DOUGLAS | Director | February 20, 2024 |
| Robert Douglas | ||
| /s/ DANIEL T. LEMAITRE | Director | February 20, 2024 |
| Daniel T. Lemaitre | ||
| /s/ ANN D. RHOADS | Director | February 20, 2024 |
| Ann D. Rhoads | ||
| /s/ JAMES R. TOBIN | Director | February 20, 2024 |
| James R. Tobin | ||
| /s/ STEPHEN T. ZARRILLI | Director | February 20, 2024 |
| Stephen T. Zarrilli | ||
| /s/ JOHN A. DEFORD | Director | February 20, 2024 |
| John A. DeFord | ||
| /s/ DANIEL J. WOLTERMAN | Director | February 20, 2024 |
| Daniel J. Wolterman | ||
| /s/ LESLIE V. NORWALK | Director | February 20, 2024 |
| Leslie V. Norwalk | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.